204 related articles for article (PubMed ID: 31440035)
1. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
Son M; Guk J; Kim Y; Woo Chae D; Heo YA; Soh D; Park K
Clin Ther; 2016 Aug; 38(8):1845-57. PubMed ID: 27422590
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study.
Son M; Kim Y; Lee D; Roh H; Son H; Guk J; Jang SB; Nam SY; Park K
Clin Ther; 2014 Aug; 36(8):1147-58. PubMed ID: 24998012
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.
Huh KY; Lee SW; Lee SB; Kim KT; Jang IJ; Lee S
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1290-1296. PubMed ID: 33647189
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
Oh M; Ghim JL; Park SE; Kim EY; Shin JG
Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
Moon SJ; Jeon JY; Yu KS; Kim MG
Clin Ther; 2019 Nov; 41(11):2273-2282. PubMed ID: 31564513
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
Park JS; Jeon JY; Kim MG
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects.
Kim CH; Kang SI; Shin D
Adv Ther; 2021 Feb; 38(2):1094-1105. PubMed ID: 33326064
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between rosuvastatin and olmesartan: a randomized, open-label, 3-period, multiple-dose crossover study in healthy Korean male subjects.
Roh H; Son H; Lee D; Chang H; Yun C; Park K
Clin Ther; 2014 Aug; 36(8):1159-70. PubMed ID: 25017182
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
Lee J; Rhee SJ; Lee S; Yu KS
Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
Chae DW; Son M; Kim Y; Son H; Jang SB; Seo JM; Nam SY; Park K
Int J Clin Pharmacol Ther; 2015 Oct; 53(10):883-9. PubMed ID: 26329347
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between rosuvastatin and metformin in healthy Korean male volunteers: a randomized, open-label, 3-period, crossover, multiple-dose study.
Lee D; Roh H; Son H; Jang SB; Lee S; Nam SY; Park K
Clin Ther; 2014 Aug; 36(8):1171-81. PubMed ID: 24976448
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects.
Kim CH; An H; Kim SH; Shin D
Drug Des Devel Ther; 2017; 11():3461-3469. PubMed ID: 29255347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
